0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Metastatic Colorectal Cancer Surgery Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39F5966
Home | Market Reports | Health| Health Conditions| Cancer
Global Metastatic Colorectal Cancer Surgery Market Insights and Forecast to 2028
BUY CHAPTERS

Global Metastatic Colorectal Cancer Surgery Market Research Report 2025

Code: QYRE-Auto-39F5966
Report
September 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Metastatic Colorectal Cancer Surgery Market

The global market for Metastatic Colorectal Cancer Surgery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
This report aims to provide a comprehensive presentation of the global market for Metastatic Colorectal Cancer Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Colorectal Cancer Surgery.
The Metastatic Colorectal Cancer Surgery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metastatic Colorectal Cancer Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metastatic Colorectal Cancer Surgery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Metastatic Colorectal Cancer Surgery Market Report

Report Metric Details
Report Name Metastatic Colorectal Cancer Surgery Market
Segment by Type
  • Tumor Resection
  • Portal Vein Embolization
Segment by Application
  • Hospitals
  • Clinics
  • Cancer Research Centers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech, EMD Serono, Suzhou Zelgen Biopharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Surgery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Metastatic Colorectal Cancer Surgery Market report?

Ans: The main players in the Metastatic Colorectal Cancer Surgery Market are Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech, EMD Serono, Suzhou Zelgen Biopharmaceuticals

What are the Application segmentation covered in the Metastatic Colorectal Cancer Surgery Market report?

Ans: The Applications covered in the Metastatic Colorectal Cancer Surgery Market report are Hospitals, Clinics, Cancer Research Centers

What are the Type segmentation covered in the Metastatic Colorectal Cancer Surgery Market report?

Ans: The Types covered in the Metastatic Colorectal Cancer Surgery Market report are Tumor Resection, Portal Vein Embolization

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tumor Resection
1.2.3 Portal Vein Embolization
1.3 Market by Application
1.3.1 Global Metastatic Colorectal Cancer Surgery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Colorectal Cancer Surgery Market Perspective (2020-2031)
2.2 Global Metastatic Colorectal Cancer Surgery Growth Trends by Region
2.2.1 Global Metastatic Colorectal Cancer Surgery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Metastatic Colorectal Cancer Surgery Historic Market Size by Region (2020-2025)
2.2.3 Metastatic Colorectal Cancer Surgery Forecasted Market Size by Region (2026-2031)
2.3 Metastatic Colorectal Cancer Surgery Market Dynamics
2.3.1 Metastatic Colorectal Cancer Surgery Industry Trends
2.3.2 Metastatic Colorectal Cancer Surgery Market Drivers
2.3.3 Metastatic Colorectal Cancer Surgery Market Challenges
2.3.4 Metastatic Colorectal Cancer Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Colorectal Cancer Surgery Players by Revenue
3.1.1 Global Top Metastatic Colorectal Cancer Surgery Players by Revenue (2020-2025)
3.1.2 Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Players (2020-2025)
3.2 Global Metastatic Colorectal Cancer Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Metastatic Colorectal Cancer Surgery Revenue
3.4 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio
3.4.1 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Surgery Revenue in 2024
3.5 Global Key Players of Metastatic Colorectal Cancer Surgery Head office and Area Served
3.6 Global Key Players of Metastatic Colorectal Cancer Surgery, Product and Application
3.7 Global Key Players of Metastatic Colorectal Cancer Surgery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Colorectal Cancer Surgery Breakdown Data by Type
4.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Type (2020-2025)
4.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2026-2031)
5 Metastatic Colorectal Cancer Surgery Breakdown Data by Application
5.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Application (2020-2025)
5.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Metastatic Colorectal Cancer Surgery Market Size (2020-2031)
6.2 North America Metastatic Colorectal Cancer Surgery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2020-2025)
6.4 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Surgery Market Size (2020-2031)
7.2 Europe Metastatic Colorectal Cancer Surgery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2020-2025)
7.4 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size (2020-2031)
8.2 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2020-2025)
8.4 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Surgery Market Size (2020-2031)
9.2 Latin America Metastatic Colorectal Cancer Surgery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2020-2025)
9.4 Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size (2020-2031)
10.2 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2020-2025)
10.4 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Metastatic Colorectal Cancer Surgery Introduction
11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Metastatic Colorectal Cancer Surgery Introduction
11.2.4 Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Metastatic Colorectal Cancer Surgery Introduction
11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.3.5 Eli Lilly Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Metastatic Colorectal Cancer Surgery Introduction
11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Colorectal Cancer Surgery Introduction
11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Metastatic Colorectal Cancer Surgery Introduction
11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Taiho Oncology
11.7.1 Taiho Oncology Company Details
11.7.2 Taiho Oncology Business Overview
11.7.3 Taiho Oncology Metastatic Colorectal Cancer Surgery Introduction
11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.7.5 Taiho Oncology Recent Development
11.8 Genentech
11.8.1 Genentech Company Details
11.8.2 Genentech Business Overview
11.8.3 Genentech Metastatic Colorectal Cancer Surgery Introduction
11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.8.5 Genentech Recent Development
11.9 EMD Serono
11.9.1 EMD Serono Company Details
11.9.2 EMD Serono Business Overview
11.9.3 EMD Serono Metastatic Colorectal Cancer Surgery Introduction
11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.9.5 EMD Serono Recent Development
11.10 Suzhou Zelgen Biopharmaceuticals
11.10.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Introduction
11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025)
11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tumor Resection
 Table 3. Key Players of Portal Vein Embolization
 Table 4. Global Metastatic Colorectal Cancer Surgery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Metastatic Colorectal Cancer Surgery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Metastatic Colorectal Cancer Surgery Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Metastatic Colorectal Cancer Surgery Market Share by Region (2020-2025)
 Table 8. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Metastatic Colorectal Cancer Surgery Market Share by Region (2026-2031)
 Table 10. Metastatic Colorectal Cancer Surgery Market Trends
 Table 11. Metastatic Colorectal Cancer Surgery Market Drivers
 Table 12. Metastatic Colorectal Cancer Surgery Market Challenges
 Table 13. Metastatic Colorectal Cancer Surgery Market Restraints
 Table 14. Global Metastatic Colorectal Cancer Surgery Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Metastatic Colorectal Cancer Surgery Market Share by Players (2020-2025)
 Table 16. Global Top Metastatic Colorectal Cancer Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2024)
 Table 17. Ranking of Global Top Metastatic Colorectal Cancer Surgery Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Surgery Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Metastatic Colorectal Cancer Surgery, Headquarters and Area Served
 Table 20. Global Key Players of Metastatic Colorectal Cancer Surgery, Product and Application
 Table 21. Global Key Players of Metastatic Colorectal Cancer Surgery, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Metastatic Colorectal Cancer Surgery Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Type (2020-2025)
 Table 25. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Type (2026-2031)
 Table 27. Global Metastatic Colorectal Cancer Surgery Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Application (2020-2025)
 Table 29. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Application (2026-2031)
 Table 31. North America Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Metastatic Colorectal Cancer Surgery Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Metastatic Colorectal Cancer Surgery Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Sanofi Company Details
 Table 47. Sanofi Business Overview
 Table 48. Sanofi Metastatic Colorectal Cancer Surgery Product
 Table 49. Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 50. Sanofi Recent Development
 Table 51. Roche Company Details
 Table 52. Roche Business Overview
 Table 53. Roche Metastatic Colorectal Cancer Surgery Product
 Table 54. Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 55. Roche Recent Development
 Table 56. Eli Lilly Company Details
 Table 57. Eli Lilly Business Overview
 Table 58. Eli Lilly Metastatic Colorectal Cancer Surgery Product
 Table 59. Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 60. Eli Lilly Recent Development
 Table 61. Pfizer Company Details
 Table 62. Pfizer Business Overview
 Table 63. Pfizer Metastatic Colorectal Cancer Surgery Product
 Table 64. Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 65. Pfizer Recent Development
 Table 66. Novartis Company Details
 Table 67. Novartis Business Overview
 Table 68. Novartis Metastatic Colorectal Cancer Surgery Product
 Table 69. Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 70. Novartis Recent Development
 Table 71. Amgen Company Details
 Table 72. Amgen Business Overview
 Table 73. Amgen Metastatic Colorectal Cancer Surgery Product
 Table 74. Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 75. Amgen Recent Development
 Table 76. Taiho Oncology Company Details
 Table 77. Taiho Oncology Business Overview
 Table 78. Taiho Oncology Metastatic Colorectal Cancer Surgery Product
 Table 79. Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 80. Taiho Oncology Recent Development
 Table 81. Genentech Company Details
 Table 82. Genentech Business Overview
 Table 83. Genentech Metastatic Colorectal Cancer Surgery Product
 Table 84. Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 85. Genentech Recent Development
 Table 86. EMD Serono Company Details
 Table 87. EMD Serono Business Overview
 Table 88. EMD Serono Metastatic Colorectal Cancer Surgery Product
 Table 89. EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 90. EMD Serono Recent Development
 Table 91. Suzhou Zelgen Biopharmaceuticals Company Details
 Table 92. Suzhou Zelgen Biopharmaceuticals Business Overview
 Table 93. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Product
 Table 94. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2020-2025) & (US$ Million)
 Table 95. Suzhou Zelgen Biopharmaceuticals Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Metastatic Colorectal Cancer Surgery Picture
 Figure 2. Global Metastatic Colorectal Cancer Surgery Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Metastatic Colorectal Cancer Surgery Market Share by Type: 2024 VS 2031
 Figure 4. Tumor Resection Features
 Figure 5. Portal Vein Embolization Features
 Figure 6. Global Metastatic Colorectal Cancer Surgery Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Metastatic Colorectal Cancer Surgery Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinics Case Studies
 Figure 10. Cancer Research Centers Case Studies
 Figure 11. Metastatic Colorectal Cancer Surgery Report Years Considered
 Figure 12. Global Metastatic Colorectal Cancer Surgery Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Metastatic Colorectal Cancer Surgery Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Metastatic Colorectal Cancer Surgery Market Share by Region: 2024 VS 2031
 Figure 15. Global Metastatic Colorectal Cancer Surgery Market Share by Players in 2024
 Figure 16. Global Top Metastatic Colorectal Cancer Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Surgery Revenue in 2024
 Figure 18. North America Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Metastatic Colorectal Cancer Surgery Market Share by Country (2020-2031)
 Figure 20. United States Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Metastatic Colorectal Cancer Surgery Market Share by Country (2020-2031)
 Figure 24. Germany Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Share by Region (2020-2031)
 Figure 32. China Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Metastatic Colorectal Cancer Surgery Market Share by Country (2020-2031)
 Figure 40. Mexico Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Share by Country (2020-2031)
 Figure 44. Turkey Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 48. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 49. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 50. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 52. Amgen Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 53. Taiho Oncology Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 54. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 55. EMD Serono Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 56. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart